Immix Biopharma, Inc.IMMXNASDAQ
Loading
Year-over-year net income growth rate
Percentile
P50
Within normal range
vs 5Y Ago
-1.2x
Contraction
Streak
1 qtr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| Q3 2025 | -14.54% |
| Q2 2025 | -45.79% |
| Q1 2025 | 5.60% |
| Q4 2024 | 32.69% |
| Q3 2024 | -62.75% |
| Q2 2024 | 16.47% |
| Q1 2024 | -3.33% |
| Q4 2023 | -18.90% |
| Q3 2023 | -19.70% |
| Q2 2023 | -44.22% |
| Q1 2023 | 34.74% |
| Q4 2022 | -147.54% |
| Q3 2022 | 1.77% |
| Q2 2022 | -17.32% |
| Q1 2022 | 94.15% |
| Q4 2021 | -5542.77% |
| Q3 2021 | -93.28% |
| Q2 2021 | 79.48% |
| Q1 2021 | -32.80% |
| Q4 2020 | -558.17% |
| Q3 2020 | 12.53% |
| Q2 2020 | 0.00% |
| Q1 2020 | 0.00% |